{
  "id": 16143703,
  "title": "Kestra Medical Technologies CEO sells $443,389 of company stock",
  "url": "https://urgent.news/2026/10/23/kestra-medical-technologies-ceo-sells-443-389-of-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-23T02:19:29.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/kestra-medical-technologies-ceo-sells-443389-of-company-stock-93CH-4967951"
  },
  "original_language": "en",
  "account": "Kestra Medical Technologies CEO Brian Daniel Webster sold 15,000 shares of company stock on October 20, 2026, netting $443,389. The transactions occurred at prices between $29.5172 and $29.892 per share, as the stock neared its 52-week high of $30.00, currently trading at $28.32. The sales were executed under a pre-established Rule 10b5-1 plan, adopted on July 21, 2026. Following the sale, Mr. Webster still holds 445,215 shares of Kestra Medical Technologies. Despite the stock appearing overvalued at current levels, the company has seen a strong 24.65% return over the past six months, with revenue soaring 60.72%. Kestra Medical remains unprofitable, with earnings per share at -$2.68 over the last twelve months. The company has raised its full-year revenue guidance to $141 million from $137 million. Kestra Medical Technologies' shares were rated Buy and Overweight by Stifel and Piper Sandler, respectively, with price targets of $30.00 and $34.00.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}